Cipla Bags Exclusive US Rights for Keytruda Biosimilar
Cipla InvaGen signed an exclusive deal with Qilu Pharmaceutical to license QL2107, a Keytruda biosimilar, in the US. For those wondering what a biosimilar actually...
Tag : Cipla
Cipla Shares Gain After Cancer Drug Licensing Deal
Cipla shares touched a day high of ₹1,425.70 on Tuesday morning, moving higher after signing a licensing deal for an experimental cancer drug. The company...
Cipla InvaGen Facility Gets VAI Status From USFDA
Cipla has disclosed that the USFDA classified its InvaGen New York plant inspection as Voluntary Action Indicated, closing the regulatory review. The plant is Unit...
Pharma Shares Crash Trump Issues Letter for Lowered Prices
Shares of prominent pharmaceutical companies fell substantially as investors assessed the impact of US President Trump’s letter to 17 global drug majors requesting that they...
Shares of Pharmaceutical Companies Slump on Trump’s Plan
Following President Trump’s signing of an Executive Order to boost domestic drug production facilities, leading pharmaceutical exporters to the United States may risk commercial disruption,...
Cipla Shares Rallied 5% on Securing Approval from USFDA
The share price of Cipla Ltd rallied 5% on 11 April after the company announced securing approval from the US Food and Drug Administration (USFDA)...
Cipla Shares Traded 1.51% Lower on Inspection by USFDA
Shares of Cipla Ltd. sank 1.51% on a routine current Good Manufacturing Practices (cGMP) inspection conducted by the United States Food and Drug Administration (USFDA)...
Sanofi India and Cipla Shares Trade Higher on Singing a Distribution Agreement
Shares of Sanofi India Ltd and Cipla Ltd were trading 5.4% and 1.6% higher on 27 March after the companies announced signing a distribution agreement...
Cipla Shares Trade Lower on Acquiring Additional Stake in JV
Shares of Cipla were trading in the red on 28 November after its European subsidiary, Cipla EU, acquired an additional stake in its Joint Venture...
Cipla Receives US FDA Letter Flagging Data Issues at MP Unit, Stock Emerges Top Nifty Losers
On November 23, 2023, Cipla, a prominent pharmaceutical company, witnessed a nearly 7% decline in its stock following the issuance of a warning letter by...